Royalty Conditions. The royalties under Section 8.4.1 shall be subject to the following conditions:
Appears in 17 contracts
Samples: License Agreement (Homology Medicines, Inc.), License Agreement (Immunome Inc.), License Agreement
Royalty Conditions. The royalties under Section 8.4.1 8.3.1 shall be subject to the following conditions:
Appears in 7 contracts
Samples: Sublicense Agreement (Ligand Pharmaceuticals Inc), Sublicense Agreement (Ligand Pharmaceuticals Inc), Sublicense Agreement (Desert Gateway, Inc.)
Royalty Conditions. The royalties under Section 8.4.1 8.3 shall be subject to the following conditions:
Appears in 3 contracts
Samples: Collaboration, Development and License Agreement (Zai Lab LTD), Collaboration, Development and License Agreement (TESARO, Inc.), Collaboration, Development and License Agreement (TESARO, Inc.)
Royalty Conditions. The royalties under Section 8.4.1 5.5.1 and 5.5.2 shall be subject to the following conditions:
Appears in 3 contracts
Samples: Collaboration and License Agreement (Lexicon Pharmaceuticals, Inc.), Collaboration and License Agreement (Lexicon Genetics Inc/Tx), Collaboration and License Agreement (Lexicon Genetics Inc/Tx)
Royalty Conditions. The royalties under this Section 8.4.1 4.3 shall be subject to the following conditions:
Appears in 3 contracts
Samples: License Agreement (RayzeBio, Inc.), License Agreement (RayzeBio, Inc.), License Agreement (RayzeBio, Inc.)
Royalty Conditions. The royalties under Section 8.4.1 Sections 8.1, 8.3 and/or 8.4 shall be subject to the following conditions:
Appears in 2 contracts
Samples: License Agreement (Zai Lab LTD), License Agreement (Zai Lab LTD)
Royalty Conditions. The royalties under Section 8.4.1 this Article 5 shall be subject to the following conditions:
Appears in 2 contracts
Samples: License and Option Agreement (3 Dimensional Pharmaceuticals Inc), Discovery Collaboration Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Conditions. The royalties under Section 8.4.1 5.4 shall be subject to the following conditions:
Appears in 1 contract
Samples: Collaboration and License Agreement (Isis Pharmaceuticals Inc)
Royalty Conditions. The royalties under Section 8.4.1 6.1(a) shall be subject to the following conditions:
Appears in 1 contract
Royalty Conditions. The royalties under this Section 8.4.1 5.2 shall be subject to the following conditions:
Appears in 1 contract
Royalty Conditions. The royalties under this Section 8.4.1 5.5 shall be subject to the following conditions:
Appears in 1 contract
Royalty Conditions. The royalties under this Section 8.4.1 2.9 shall be subject to the following conditions:
Appears in 1 contract
Samples: Collaboration Agreement (Structure Therapeutics Inc.)
